July 21, 2016
2 min read
Save

Study shows similarities between ankylosing spondylitis, non-radiographic axial spondyloarthritis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A multi-country prospective observational study showed patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis had comparable clinical features and disease burden and experienced a long delay in referral to rheumatologists.

“Patients with ankylosing spondylitis (AS) and non-radiographic axial [spondyloarthritis] SpA (nr-axSpA), as classified by Assessment of Spondyloarthritis International Society (ASAS) criteria, have comparable disease activity and burden,” Robert D. Inman, MD, of the University of Toronto, Canada, told Healio.com/Rheumatology. “Delays in diagnosis were mainly due to delays in referrals to rheumatologists.”

Inman and colleagues identified 2,084 patients with AS. Of these patients, 60% had AS and 40% had nr-axSpA. At yearly follow-up visits, researchers assessed disease activity, physical function, quality of life, productivity and pelvic X-rays.

Investigators found 85% of patients had human leukocyte antigen-B27 tested and results showed 68% of these patients had a positive human leukocyte antigen-B27. According to results, patients were in their mid-30s, had a long delay in referral to a rheumatologist and were recently diagnosed with axial spondyloarthritis.

Within 6 months of the baseline visit, 1,635 patients underwent pelvic X-rays and researchers noted 1,344 of these patients had X-rays scored by both local and central readers. After central reading, results showed 83.3% of the 1,344 patients retained their classification of AS or nr-axSpA vs. 16.7% of patients who received a different classification. Researchers found substantial agreement on the grading of X-rays between local and central readers, according to kappa value.

“Although there were some numerical differences between AS and nr-axSpA patients in bath ankylosing spondylitis disease activity index (BASDAI) (higher in nr-axSpA) and ankylosing spondylitis disease activity score containing C-reactive protein (ASDAS-CRP) (higher in AS), those were not considered clinically meaningful,” Inman said. “Higher ASDAS-CRP in AS patients was owing to higher levels of CRP as a laboratory marker of inflammation. Comparable clinical disease activity and burden in this large cohort of patients in rheumatology clinical practice reinforces the need for a similar treatment approach in AS and nr-axSpA patients.” – by Casey Tingle

Reference:

Inman RD, et al. Abstract #THU0407. Presented at: EULAR Annual Congress; June 8-11, 2016; London.

Disclosures: Inman received grant or research support from, is a consultant for and is on the speakers bureau of AbbVie, Amgen, Janssen, Pfizer and UCB. Please see the full abstract for a list of all other authors’ relevant financial disclosures.